GFAP and Alzheimer disease: CUR also reduced the number of hypertrophic astrocytes in the hippocampus of Aβ(1-40)-treated mice, countered downregulated mRNA expression of the glial fibrillar acidic protein (GFAP) and improved the spatial memory disorders (such disorders being symptomatic in AD) [79].